The KRAS signaling pathway is highly involved in cell proliferation and division; it belongs to the RAS/MAPK pathway, and in the oncogenic context, KRAS has very important effects in the carcinogenesis process of endometrial, colorectal, bladder, breast, and cervical cancer [79,80,81,82,83,84,85,86]. This evidence concerns the gene KRAS and cervical cancer.